Market Cap (In TWD)
1.69 Billion
Revenue (In TWD)
46.07 Million
Net Income (In TWD)
-70.83 Million
Avg. Volume
235.7 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 14.4-29.25
- PE
- -15.44
- EPS
- -1.02
- Beta Value
- 0.727
- ISIN
- TW0004172002
- CUSIP
- -
- CIK
- -
- Shares
- 107576000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Weihua Hao
- Employee Count
- -
- Website
- https://www.innopharmax.com
- Ipo Date
- 2012-09-13
- Details
- InnoPharmax Inc., a specialty pharmaceutical company, develops and commercializes products for the treatment of oncology and other specialties in Taiwan. The company's core products include N11005, a prandial oral insulin; and GemOral. It also offers Imipenem and Cilastatin solution for the treatment of infections caused by susceptible organisms, such as lower respiratory tract, skin and skin structure, intra-abdominal, gynecologic, bone, and joint infections; contrast agents consisting of gadopentetate dimeglumine and gadodiamide; oncology agents comprising Innomustine and Immurin; and Inpheno tablets for rare diseases. In addition, the company provides MUCR system, OralPas, and OralPas Pro technology platform. Its product pipeline comprises D07001, which is in phase I trial for treatment of tumor; C08001, which is in phase lll for the treatment of hypertension, heart failure and left ventricular dysfunction following myocardial infarction; D07002, which is in pilot BE trial used as a supplement for phenylketonuria; and C07001, which is in pilot BE trial for the treatment of parkinson's disease; N11001, which is in pilot BE as urology agents; and D0131502 and D0051301 as contrast agents and is in formulation. The company was founded in 1994 and is based in Taipei, Taiwan.
More Stocks
-
MOTHERSON
-
4901
-
BHOOYboohoo group plc
BHOOY
-
0P59
-
ASAL
-
CREATIVECreative Newtech Limited
CREATIVE
-
2730EDION Corporation
2730
-
UNIDT